Publications by authors named "Talitha Verhoef"

Claim this Profile
E
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.
Elisa Danese, Sara Raimondi, Martina Montagnana, Angela Tagetti, Taimour Langaee, Talitha I Verhoef

Clin Pharmacol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study.
Estela Capelas Barbosa, Talitha Irene Verhoef, Steve Morris, Francesca Solmi, Medina Johnson

BMJ Open· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis.
Austen El-Osta, Maria Woringer, Elena Pizzo, Talitha Verhoef, Claire Dickie

BMJ Open· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time and travel costs incurred by women attending antenatal tests: A costing study.
Talitha I Verhoef, Rebecca Daley, Laura Vallejo-Torres, Lyn S Chitty, Stephen Morris

Midwifery· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways.
Talitha I Verhoef, Melissa Hill, Suzanne Drury, Sarah Mason, Lucy Jenkins

Prenat Diagn· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Lyn S Chitty, David Wright, Melissa Hill, Talitha I Verhoef, Rebecca Daley

BMJ· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of offering free leisure centre memberships to physically inactive members of the public receiving state benefits: a case study.
Talitha I Verhoef, Verena Trend, Barry Kelly, Nigel Robinson, Paul Fox

BMC Public Health· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a physical exercise programme for residents of care homes: a pilot study.
Talitha I Verhoef, Parita Doshi, Dan Lehner, Stephen Morris

BMC Geriatr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study.
Talitha I Verhoef, Stephen Morris, Anthony Mathur, Mervyn Singer

BMJ Open· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.
Melissa Hill, Philip Twiss, Talitha I Verhoef, Suzanne Drury, Fiona McKay

Prenat Diagn· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants.
Camilla L Marvig, Talitha I Verhoef, Anthonius de Boer, Farhad Kamali, Ken Redekop

Thromb Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands.
Yumao Zhang, Anthonius de Boer, Talitha I Verhoef, Felix J M van der Meer, Saskia Le Cessie

Thromb Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-guided coumarin dosing: where are we now and where do we need to go next?
Ekaterina V Baranova, Talitha I Verhoef, Folkert W Asselbergs, Anthonius de Boer, Anke-Hilse Maitland-van der Zee

Expert Opin Drug Metab Toxicol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and pricing of antibacterial drugs.
Talitha I Verhoef, Stephen Morris

Chem Biol Drug Des· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The Netherlands.
Talitha I Verhoef, William K Redekop, Anthonius de Boer, Anke Hilse Maitland-van der Zee,

Pharmacogenomics· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings.
Talitha I Verhoef, William K Redekop, Fazila Hasrat, Anthonius de Boer, Anke Hilse Maitland-van der Zee

Am J Cardiovasc Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users.
Talitha I Verhoef, W Ken Redekop, Marcel L Bouvy, Brenda Dorenbos, Zamiera Karwar

Br J Clin Pharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.
Talitha I Verhoef, William K Redekop, Ann K Daly, Rianne M F van Schie, Anthonius de Boer

Br J Clin Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Talitha I Verhoef, Georgia Ragia, Anthonius de Boer, Rita Barallon, Genovefa Kolovou

N Engl J Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose.
Rianne M F van Schie, Talitha I Verhoef, Saskia B Boejharat, Tom Schalekamp, Judith A M Wessels

Drug Metabol Drug Interact· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.
Talitha I Verhoef, William K Redekop, David L Veenstra, Rahber Thariani, Peter A Beltman

Pharmacogenomics· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance dose.
Rianne M F van Schie, Judith A M Wessels, Talitha I Verhoef, Tom Schalekamp, Saskia le Cessie

Pharmacogenomics· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs.
Talitha I Verhoef, William K Redekop, Rianne Mf van Schie, Samira Bayat, Ann K Daly

Pharmacogenomics· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study.
Rianne M F van Schie, Nadia el Khedr, Talitha I Verhoef, Martina Teichert, Bruno H Stricker

Pharmacogenomics· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis